Volume 8, Issue 2 (2-2018)                   Iran J Ped Hematol Oncol 2018, 8(2): 139-141 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Efficacy of Tranexamic Acid in Severe Pulmonary Hemorrhage in a Asphyctic Neonate. Iran J Ped Hematol Oncol. 2018; 8 (2) :139-141
URL: http://ijpho.ssu.ac.ir/article-1-309-en.html
Abstract:   (832 Views)
Pulmonary hemorrhage (PH) is rarely seen in neonates and generally occurs based on the pathological process as perinatal asphyxia. Additionally, hypothermia treatment can be associated with thrombocytopenia and hemorrhage in term infants. Generally, PH is severe and persistant hemorrhage can related to neonatal mortality. Sometimes, supportive therapies such as positive-end expiratory pressure (PEEP), antibiotherapy, and fresh frozen plasma may not affect PE in neonates. Tranexamic acid (TXA) is an antifibrinolytic agent that can reduce bleeding and decrease blood transfusions in pediatric surgery. In this study, a 5-year-old girl was reorted that who was presented with a 4 month history of pelvic and right lower limb pain and limping to the pediatric outpatient clinic in August 2016  at Shahid sadoughi Hospital,Yazd,Iran. In this case report, a severe PH was presented and treated with TXA. PH was reduced after administering first dose of TXA and full recovery was achieved on 3th day of therapy. No bacterial agent was observed in hemoculture result during first 72 hours and hemocoagulation was not affected with TXA administration.
Full-Text [PDF 160 kb]   (615 Downloads)    
Type of Study: case report | Subject: Special
Received: 2017/06/12 | Accepted: 2018/02/5 | Published: 2018/02/27

Add your comments about this article : Your username or Email:

© 2019 All Rights Reserved | Iranian Journal of Pediatric Hematology and Oncology

Designed & Developed by : Yektaweb